Search by Drug Name or NDC
NDC 36000-0302-25 methocarbamol 100 mg/mL Details
methocarbamol 100 mg/mL
methocarbamol is a INTRAMUSCULAR; INTRAVENOUS INJECTION in the HUMAN PRESCRIPTION DRUG category. It is labeled and distributed by Baxter Healthcare Corporation. The primary component is METHOCARBAMOL.
Product Information
| NDC | 36000-0302 |
|---|---|
| Product ID | 36000-302_cef381b6-94f1-44f1-a014-49cba9dd0e2b |
| Associated GPIs | |
| GCN Sequence Number | n/a |
| GCN Sequence Number Description | n/a |
| HIC3 | n/a |
| HIC3 Description | n/a |
| GCN | n/a |
| HICL Sequence Number | n/a |
| HICL Sequence Number Description | n/a |
| Brand/Generic | n/a |
| Proprietary Name | methocarbamol |
| Proprietary Name Suffix | n/a |
| Non-Proprietary Name | methocarbamol |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Dosage Form | INJECTION |
| Route | INTRAMUSCULAR; INTRAVENOUS |
| Active Ingredient Strength | 100 |
| Active Ingredient Units | mg/mL |
| Substance Name | METHOCARBAMOL |
| Labeler Name | Baxter Healthcare Corporation |
| Pharmaceutical Class | Centrally-mediated Muscle Relaxation [PE], Muscle Relaxant [EPC] |
| DEA Schedule | n/a |
| Marketing Category | ANDA |
| Application Number | ANDA215065 |
| Listing Certified Through | 2024-12-31 |
Package
NDC 36000-0302-25 (36000030225)
| NDC Package Code | 36000-302-25 |
|---|---|
| Billing NDC | 36000030225 |
| Package | 25 VIAL in 1 CARTON (36000-302-25) / 10 mL in 1 VIAL (36000-302-01) |
| Marketing Start Date | 2022-07-14 |
| NDC Exclude Flag | N |
| Pricing Information | N/A |